Regen BioPharma, Inc. (RGBP)
OTCMKTS · Delayed Price · Currency is USD
0.0890
+0.0318 (55.59%)
Jul 18, 2025, 4:00 PM EDT
Regen BioPharma Market Cap
Regen BioPharma has a market cap or net worth of $2.81 million as of July 18, 2025. Its market cap has decreased by -27.39% in one year.
Market Cap
2.81M
Enterprise Value
3.78M
Revenue
236.56K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.09
Market Cap Chart
Since September 4, 2014, Regen BioPharma's market cap has decreased from 19.72M to 2.81M, a decrease of -85.76%. That is a compound annual growth rate of -16.41%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.62B |
| Veradigm | 832.17M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 608.62M |
| Glass House Brands | 450.03M |
| CytoDyn | 395.39M |
| Northwest Biotherapeutics | 382.15M |